In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Type 1 selected

Type

Guidance programme

Showing 1 to 4 of 4

TitleTypeExpected publication date
Cladribine for treating relapsing multiple sclerosis [ID6263]Technology appraisal guidance
Evobrutinib for treating relapsing multiple sclerosis [ID6313]Technology appraisal guidanceTBC
Multiple sclerosis (relapsing, remitting, highly active) - natalizumab and Tyruko (natalizumab biosimilar) (after disease modifying therapy) [ID6369]Technology appraisal guidance
Ublituximab for treating relapsing multiple sclerosis [ID6350]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All